Literature DB >> 29299091

Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT.

Christopher J Smith1, Mindy X Wang1, Michael Feely2, Brandon Otto3, Joseph R Grajo1.   

Abstract

Renal oncocytoma is a benign renal neoplasm that is often discovered incidentally and closely mimics renal cell carcinoma on common imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). Due to the inability to reliably distinguish between these benign and malignant lesions with imaging, both are typically treated as if they are malignant. Hypermetabolic activity of renal oncocytomas is not frequently encountered because positron emission tomography (PET) is not a standard modality for imaging primary renal tumors. We present a case of a 65 year-old female with a history of thyroid cancer who had an incidentally discovered hypermetabolic renal mass on surveillance PET-CT imaging. Due to the concern for a primary renal malignancy or metastatic disease, the mass was resected and proven to be an oncocytoma on pathologic review.

Entities:  

Keywords:  FDG-avid; Oncocytoma; PET/CT; Renal cell carcinoma; Renal mass

Mesh:

Substances:

Year:  2017        PMID: 29299091      PMCID: PMC5743137          DOI: 10.3941/jrcr.v11i5.3117

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  18 in total

1.  Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.

Authors:  Manish Dhyani; Joseph R Grajo; Dayron Rodriguez; Zhikui Chen; Adam Feldman; Rosemary Tambouret; Debra A Gervais; Ronald S Arellano; Peter F Hahn; Anthony E Samir
Journal:  Abdom Radiol (NY)       Date:  2017-06

2.  Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.

Authors:  Jingtao Wu; Qingqiang Zhu; Wenrong Zhu; Wenxin Chen; Shouan Wang
Journal:  Acta Radiol       Date:  2015-05-13       Impact factor: 1.990

3.  Incidental Bilateral Renal Oncocytoma in a Patient with Metastatic Carcinoma of Unknown Primary: a Pitfall on (18)F-FDG PET/CT.

Authors:  William Makis; Anthony Ciarallo; Javier-A Novales-Diaz; Robert Lisbona
Journal:  Nucl Med Mol Imaging       Date:  2011-07-13

4.  Giant renal oncocytoma: a case report and review of the literature.

Authors:  Sami Akbulut; Ayhan Senol; Bahri Cakabay; Arsenal Sezgin
Journal:  J Med Case Rep       Date:  2010-02-17

5.  HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.

Authors:  James R Conner; Michelle S Hirsch; Vickie Y Jo
Journal:  Cancer Cytopathol       Date:  2015-03-04       Impact factor: 5.284

6.  Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.

Authors:  Vincent G Bird; Prashanth Kanagarajah; Gaston Morillo; Daniel J Caruso; Rajinikanth Ayyathurai; Raymond Leveillee; Merce Jorda
Journal:  World J Urol       Date:  2010-08-18       Impact factor: 4.226

Review 7.  Role of FDG PET/CT in imaging of renal lesions.

Authors:  R Kochhar; R K Brown; C O Wong; N R Dunnick; K A Frey; P Manoharan
Journal:  J Med Imaging Radiat Oncol       Date:  2010-08       Impact factor: 1.735

8.  Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy.

Authors:  Shuo Liu; Stephen Lee; Prem Rashid; Haider Bangash; Akhlil Hamid; Jason Lau; Ronald Cohen
Journal:  BJU Int       Date:  2016-07-26       Impact factor: 5.588

9.  Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.

Authors:  S Choudhary; A Rajesh; N J Mayer; K A Mulcahy; A Haroon
Journal:  Clin Radiol       Date:  2009-03-09       Impact factor: 2.350

10.  Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation.

Authors:  Kousei Ishigami; Aaron R Jones; Laila Dahmoush; Leandro V Leite; Marius G Pakalniskis; Thomas J Barloon
Journal:  Insights Imaging       Date:  2014-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.